JP Stock MarketDetailed Quotes

4559 Zeria Pharmaceutical

Watchlist
  • 2231
  • -29-1.28%
20min DelayNot Open Nov 14 15:30 JST
118.51BMarket Cap12.72P/E (Static)

Zeria Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Zeria Pharmaceutical H1 FY2025 Earnings Date

Currency：JPYNov 6, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
42.42B
--
+15.66%
EPS
--
137.51
--
+12.32%
Analyst Rating
Strong Buy

Jul 10, 2024

Zeria Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 0 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Aug 1, 20242025/Q121.455B / ----
May 9, 20242024/Q417.806B / 17.780B--
Feb 1, 20242024/Q321.241B / 19.470B--
Nov 1, 20232024/Q218.374B / 18.295B--
Aug 3, 20232024/Q118.304B / 17.190B--
DatePeriodRevenue/EstimateEarnings Call
Aug 1, 20242025/Q121.455B / ----
May 9, 20242024/Q417.806B / 17.780B--
Feb 1, 20242024/Q321.241B / 19.470B--
Nov 1, 20232024/Q218.374B / 18.295B--
Aug 3, 20232024/Q118.304B / 17.190B--

Unlock Free Earnings Estimates

Zeria Pharmaceutical Earnings Reports

  • Zeria Pharmaceutical: Confirmation letter

    Nov 8 09:01

  • Zeria Pharmaceutical: Half-Year Report - Term 71 (2024/04/01 - 2025/03/31)

    Nov 8 09:00

  • Zeria Pharmaceutical: Summary of financial results for the 2nd quarter (interim period) for the fiscal year ending March 31, 2025 [Japanese GAAP] (consolidated)

    Nov 6 15:00

  • Zeria Pharmaceutical: Notice regarding revisions to earnings forecasts

    Nov 5 10:00

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 10, 2024

    Strong Buy

    • Strong Buy

      100.00%

    • Buy

      0.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    JP
    Overall
    Symbol
    Latest Price
    % Chg

    No Data